The company claims their patches work through transdermal delivery that bypasses your digestive system, delivering ingredients straight into your bloodstream for enhanced bioavailability. According to their marketing, 92.3% of customers report fewer cravings and 82.3% reduce snacking, with effects visible within 4 weeks
Fans of the reclassification say that allowing compounding pharmacies to make these drugs will allow some degree of FDA oversight, and will therefore protect customers some of whom may already be injecting themselves with unproven peptides that are not intended for human use
The Lee 2016 work adds VEGF upregulation and TGF-beta-1 reduction as supporting mechanisms
One potential downside of BPC 157 is its limited clinical testing in humans, which means long-term safety and efficacy are not well-established
You should never drive with a low blood sugar level
While MT-1 doses are often in the 500mcg-1mg range, MT-2 research protocols typically use doses in the 100mcg-500mcg range